Nephrology Doctors in Hagerstown, MD Accepting Medicare

5 Nephrology doctors found. Showing 1 - 5

Khetisuda Suvarnasuddhi, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12931 Oak Hill Ave, Hagerstown, MD 21742 Phone: 301-797-9600    Fax: 301-797-3854

Anwar Iqbal, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12931 Oak Hill Ave, Hagerstown, MD 21742 Phone: 301-797-9600    Fax: 301-797-3854

Eli Roza, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12931 Oak Hill Ave, Hagerstown, MD 21742 Phone: 301-797-9600    Fax: 301-797-3854

Dr. Jeremy Ross Yospin, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12931 Oak Hill Avenue, Hagerstown, MD 21742 Phone: 301-797-9600    Fax: 301-797-3854

Eric Mark Jaurigue Lopez, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12931 Oak Hill Ave, Hagerstown, MD 21742 Phone: 301-797-9600

News Archive

Teacher supervised toothbrushing reduces dental decay in socially deprived school children

Dental decay is one of the most common preventable health problems in children living in socially deprived areas of the UK.

Researchers find link between altered dopamine activity and social anxiety disorder

Using single-photon emission computed tomography (SPECT), researchers in The Netherlands were able to detect biochemical differences in the brains of individuals with generalized social anxiety disorder (also known as social phobia), providing evidence of a long-suspected biological cause for the dysfunction.

Study of latest in clinical data technology applied to Phase II clinical trial in South Africa

Last week, at the fourth annual Clinical Trials in Emerging Economies conference, Margaret Ann Snowden, Director of Biostatistics and Data Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed Technology, presented a case study of the application of the latest in clinical data technology to a large Phase II clinical trial in South Africa. The presentation provided an update on how effective technology can be in promoting the development of affordable vaccine regimens for the prevention of tuberculosis (TB) worldwide.

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

Merck, known as MSD outside the United States and Canada, today announced final results from a Phase II clinical study, extending out to 240 weeks, of its integrase inhibitor ISENTRESS® (raltegravir) Tablets in combination therapy in previously untreated (treatment-naïve) adult HIV-1-infected patients.

Use of antimuscarinics linked to depressive disorder in women with overactive bladder

A recent study found that women with overactive bladder who received antimuscarinics were 38% more likely to be diagnosed with depressive disorder within the next 3 years than those who did not receive antimuscarinics.

Read more Medical News

› Verified 4 days ago